THOR is a targetable epigenetic biomarker with clinical implications in breast cancer. - Apolónio, Joana Dias; Dias, João S.; Fernandes, Mónica Teotónio; Komosa, Martin; Lipman, Tatiana; Zhang, Cindy H.; Leão, Ricardo; Lee, Donghyun; Nunes, Nuno Miguel; Maia, Ana-Teresa; Morera, José L.; Vicioso, Luis; et al. (Clinical Epigenetics, 2022)